These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections. Huang J; Tang YQ; Sun JY Scand J Infect Dis; 2010 Apr; 42(4):260-5. PubMed ID: 20085424 [TBL] [Abstract][Full Text] [Related]
9. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915 [TBL] [Abstract][Full Text] [Related]
10. Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia. Linden PK; Paterson DL Clin Infect Dis; 2006 Sep; 43 Suppl 2():S89-94. PubMed ID: 16894521 [TBL] [Abstract][Full Text] [Related]
11. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Falagas ME; Kasiakou SK Clin Infect Dis; 2005 May; 40(9):1333-41. PubMed ID: 15825037 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. Aoki N; Tateda K; Kikuchi Y; Kimura S; Miyazaki C; Ishii Y; Tanabe Y; Gejyo F; Yamaguchi K J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523 [TBL] [Abstract][Full Text] [Related]
14. Multidrug-resistant Gram-negative infections: the use of colistin. Michalopoulos AS; Karatza DC Expert Rev Anti Infect Ther; 2010 Sep; 8(9):1009-17. PubMed ID: 20818945 [TBL] [Abstract][Full Text] [Related]
15. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Levin AS; Barone AA; Penço J; Santos MV; Marinho IS; Arruda EA; Manrique EI; Costa SF Clin Infect Dis; 1999 May; 28(5):1008-11. PubMed ID: 10452626 [TBL] [Abstract][Full Text] [Related]
16. Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical. Sorlí L; Luque S; Li J; Campillo N; Danés M; Montero M; Segura C; Grau S; Horcajada JP J Infect; 2019 Sep; 79(3):253-261. PubMed ID: 31265867 [TBL] [Abstract][Full Text] [Related]
17. Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin. Schina M; Spyridi E; Daoudakis M; Mertzanos E; Korfias S Int J Infect Dis; 2006 Mar; 10(2):178-9. PubMed ID: 16263315 [No Abstract] [Full Text] [Related]
18. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Michalopoulos AS; Tsiodras S; Rellos K; Mentzelopoulos S; Falagas ME Clin Microbiol Infect; 2005 Feb; 11(2):115-21. PubMed ID: 15679485 [TBL] [Abstract][Full Text] [Related]
19. Current therapies for pseudomonas aeruginosa. Giamarellou H; Kanellakopoulou K Crit Care Clin; 2008 Apr; 24(2):261-78, viii. PubMed ID: 18361945 [TBL] [Abstract][Full Text] [Related]
20. Colistin and polymyxin B in critical care. Michalopoulos A; Falagas ME Crit Care Clin; 2008 Apr; 24(2):377-91, x. PubMed ID: 18361952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]